Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOVE
2876
DELISTED
LoveSac
LOVE
| $1.15M | ﹤0.01% |
40,281
-1,182
| -3% | -$29.5K |
|
2877
Climb Global Solutions
CLMB
$500M
| $1.15M | ﹤0.01% |
46,344
-208
| -0.4% | -$4.16K |
|
2878
Xeris Biopharma Holdings
XERS
$1.39B
| $1.15M | ﹤0.01% |
403,361
-1,221
| -0.3% | -$3.14K |
|
2879
UroGen Pharma
URGN
$1.86B
| $1.15M | ﹤0.01% |
90,493
+7,576
| +9% | +$112K |
|
2880
Virgin Galactic
SPCE
$328M
| $1.14M | ﹤0.01% |
187,368
+42,883
| +30% | +$287K |
|
2881
EyePoint Inc
EYPT
$1.03B
| $1.14M | ﹤0.01% |
142,763
+7,967
| +6% | +$70K |
|
|
OPRA
2882
Opera Ltd
OPRA
$1.69B
| $1.13M | ﹤0.01% |
73,417
-1,085
| -1% | -$14.6K |
|
2883
Mitek Systems
MITK
$754M
| $1.13M | ﹤0.01% |
130,781
+2,460
| +2% | +$24.9K |
|
2884
South Plains Financial
SPFI
$845M
| $1.13M | ﹤0.01% |
33,349
-946
| -3% | -$30.2K |
|
2885
Capricor Therapeutics
CAPR
$223M
| $1.12M | ﹤0.01% |
73,468
| – | – |
|
2886
Northrim BanCorp
NRIM
$590M
| $1.12M | ﹤0.01% |
62,708
+1,828
| +3% | +$29.9K |
|
2887
Orchestra BioMed
OBIO
$238M
| $1.12M | ﹤0.01% |
217,008
+8,107
| +4% | +$53K |
|
2888
Carter Bankshares
CARE
$766M
| $1.11M | ﹤0.01% |
63,826
-1,807
| -3% | -$29.7K |
|
2889
Hingham Institution for Saving
HIFS
$627M
| $1.1M | ﹤0.01% |
4,527
+137
| +3% | +$31.7K |
|
2890
Angi Inc
ANGI
$229M
| $1.1M | ﹤0.01% |
42,594
-3,508
| -8% | -$84.4K |
|
2891
Ero Copper
ERO
$2.81B
| $1.1M | ﹤0.01% |
+49,267
| New | +$1.01M |
|
2892
Consolidated Water Co
CWCO
$467M
| $1.09M | ﹤0.01% |
43,175
+1,159
| +3% | +$30.9K |
|
2893
Eve Holding
EVEX
$808M
| $1.08M | ﹤0.01% |
332,732
+129,300
| +64% | +$391K |
|
2894
Senseonics Holdings Inc
SENS
$263M
| $1.07M | ﹤0.01% |
153,243
-2,262
| -1% | -$18.2K |
|
2895
Sierra Bancorp
BSRR
$528M
| $1.07M | ﹤0.01% |
37,067
+29
| +0.1% | +$806 |
|
2896
Vanguard Financials ETF
VFH
$13.5B
| $1.07M | ﹤0.01% |
9,699
-1,596
| -14% | -$169K |
|
2897
RBB Bancorp
RBB
$448M
| $1.06M | ﹤0.01% |
45,998
-352
| -0.8% | -$7.68K |
|
2898
Prudential
PUK
$37.6B
| $1.06M | ﹤0.01% |
57,107
+2,455
| +4% | +$42.9K |
|
|
VTYX
2899
DELISTED
Ventyx Biosciences
VTYX
| $1.06M | ﹤0.01% |
485,101
+17,898
| +4% | +$41.2K |
|
2900
American Vanguard Corp
AVD
$68.4M
| $1.05M | ﹤0.01% |
198,877
-62,259
| -24% | -$441K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.